Optimal Usage of Sacubitril/Valsartan For Heart Failure Treatment In Canada Potentially Reduces Mortality, Hospitalizations And Early Discharge Re-Admissions
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.1170
https://www.valueinhealthjournal.com/article/S1098-3015(17)31504-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1119
First Page :
A605
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31504-8&doi=10.1016/j.jval.2017.08.1170